Memory Binding Test predicts incident dementia: Results from the Einstein Aging Study

Manuscript Number: 

17-0714R1

Author(s): 
Herman Buschke, Mindy J. Katz, Richard B. Lipton, David A. Loewenstein, Wenzhu B. Mowrey, Wendy S. Ramratan, Molly E. Zimmerman

Disclosures

Herman Buschke

  • Nothing to Disclose

Mindy J. Katz

  • Nothing to Disclose

Richard B. Lipton

  • Consulting Fees:
    Serve as consultant, advisory board member, or has received honoraria from: American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, Vedanta.
    Equity:
    Hold stock options in eNeura Therapeutics and Biohaven Holdings
    Lecture Fees:
    Serve as consultant, advisory board member, or has received honoraria from: American Academy of Neurology, Alder, Allergan, American Headache Society, Amgen, Autonomic Technologies, Avanir, Biohaven, Biovision, Boston Scientific, Dr. Reddy’s, Electrocore, Eli Lilly, eNeura Therapeutics, GlaxoSmithKline, Merck, Pernix, Pfizer, Supernus, Teva, Trigemina, Vector, Vedanta.
    Patents/Royalties
    Receive royalties from Wolff’s Headache, 8th Edition, Oxford Press University, 2009, Wiley and Informa.
    Grants
    • Agency: 
      Migraine Research Foundation
      Dates: 
      2015 - present

David A. Loewenstein

  • Nothing to Disclose

Wenzhu B. Mowrey

  • Nothing to Disclose

Wendy S. Ramratan

  • Nothing to Disclose

Molly E. Zimmerman

  • Nothing to Disclose